Every child and family deserves medicines developed under the highest safety standards, free from foreign dependence and compromise.
A growing reliance on overseas drug manufacturing and research puts American families’ health at risk.
Without adequate investment in U.S. biomedical research, critical studies that could unlock treatments for childhood cancers, rare genetic diseases, and other serious illnesses are being driven overseas. As a result, this work is increasingly conducted in countries that may lack strong regulatory oversight, raising concerns about the safety and reliability of future treatments.